Clinical and histological evaluation of 1% nadifloxacin cream in the treatment of acne vulgaris in Korean patients (Q34166150)

31 July 2017

title

Clinical and histological evaluation of 1% nadifloxacin cream in the treatment of acne vulgaris in Korean patients (English)

1 reference

31 July 2017

1 reference

Jae Yoon Jung

1

1 reference

31 July 2017

Hyuck Hoon Kwon

2

1 reference

31 July 2017

Kkot Bora Yeom

3

1 reference

31 July 2017

Mi Young Yoon

4

1 reference

31 July 2017

Dae Hun Suh

5

1 reference

31 July 2017

publication date

1 March 2011

1 reference

International Journal of Dermatology

31 July 2017

published in

1 reference

31 July 2017

volume

50

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

350-357

1 reference

31 July 2017

cites work

Acne: topical treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients: efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

Topical treatment in acne: current status and future aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

Topical antibacterial therapy for acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

Clinical and bacteriologic evaluation of OPC-7251 in patients with acne: A double-blind group comparison study versus cream base

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

Effect of nadifloxacin on atopic dermatitis with methicillin-resistant Staphylococcus aureus in young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

Therapeutic androgen receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

Modulation of androgen receptor transcriptional activity by anti-acne reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

Clinical considerations on the use of concomitant therapy in the treatment of acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

Efficacy and tolerance of superoxidized solution in the treatment of mild to moderate inflammatory acne. A double-blinded, placebo-controlled, parallel-group, randomized, clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

Differences of skin irritation between Japanese and European women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

Population differences in acute skin irritation responses. Race, sex, age, sensitive skin and repeat subject comparisons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

Acne vulgaris in skin of color

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

Comparison of a pulsed dye laser and a combined 585/1,064-nm laser in the treatment of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

Immunohistochemical expression of interleukin 8 in skin biopsies from patients with inflammatory acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

Effect of the admixture of tetracycline and nadifloxacin ointments on their stability and their antibacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04701.X

10.1111/J.1365-4632.2010.04701.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference